Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States

被引：0

作者：

Farber, Harrison W. ^{[1
]}

Germack, Hayley D. ^{[2
]}

Croteau, Nicole S. ^{[3
]}

Simeone, Jason C. ^{[3
]}

Tang, Fei ^{[3
]}

Paoli, Carly J. ^{[2
]}

Doad, Gurinderpal ^{[4
]}

Panjabi, Sumeet ^{[2
]}

De Marco, Teresa ^{[5
]}

机构：

[1] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA

[2] Janssen Sci Affairs LLC, Titusville, NJ USA

[3] Cytel, Real World Evidence, Waltham, MA USA

[4] Actelion Pharmaceut, Titusville, NJ USA

[5] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA

来源：

PULMONARY CIRCULATION | 2024年 / 14卷 / 02期

关键词：

pulmonary arterial hypertension; risk factors; treatment;

D O I：

10.1002/pul2.12326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation.

引用

页数：5

共 50 条

[21] Treatment of pulmonary arterial Hypertension
Schranz, Dietmar
MONATSSCHRIFT KINDERHEILKUNDE, 2014, 162 (04) : 334 - 335
[22] Treatment of pulmonary arterial hypertension
Huisman, A
Vreugdenhil, SA
van Paassen, HC
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03): : 308 - 308
[23] Treatment of pulmonary arterial hypertension
Montani, D
Sitbon, O
Jaïs, X
Cabrol, S
Simonneau, G
Humbert, M
PRESSE MEDICALE, 2005, 34 (19): : 1445 - 1455
[24] Treatment of pulmonary arterial hypertension
Roman, Antonio
Lopez-Meseguer, Manuel
Domingo, Enric
MEDICINA CLINICA, 2015, 144 (12): : 566 - 570
[25] Pulmonary Arterial Hypertension Treatment
不详
NURSE PRACTITIONER, 2007, 32 (09): : 56 - 56
[26] Treatment of pulmonary arterial hypertension
Jais, Xavier
Bonnet, Damien
PRESSE MEDICALE, 2010, 39 : 1S22 - 1S32
[27] TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Gutierrez, Fernando
Gonzalez, Itamar
Sanchez Jose, Luis
Tevar, Enrique
Vina, Ma Micaela
Merino, Javier
ATENCION FARMACEUTICA, 2010, 12 (01): : 39 - 46
[28] Real-World Treatment Patterns in Hispanic and White Patients With Pulmonary Arterial Hypertension (PAH) in the United States
Melendres-Groves, Lana
Tang, Wenze
Germack, Hayley D.
Liu, Zhiwen
Sadik, Kay
CIRCULATION, 2023, 148
[29] Racial disparities in treatment patterns, healthcare resource use, and outcomes in patients with pulmonary arterial hypertension in the United States
Melendres-Groves, Lana
Tang, Wenze
Germack, Hayley D.
Liu, Zhiwen
Sadik, Kay
CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (09) : 1465 - 1475
[30] Factors associated with hypertension control in the general population of the United States
He, J
Muntner, P
Chen, J
Roccella, EJ
Streiffer, RH
Whelton, PK
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) : 1051 - 1058

← 1 2 3 4 5 →